4//SEC Filing
George Simeon 4
Accession 0000950170-24-106978
CIK 0001953926other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 8:51 PM ET
Size
23.0 KB
Accession
0000950170-24-106978
Insider Transaction Report
Form 4
George Simeon
10% Owner
Transactions
- Conversion
Series C Convertible Preferred Stock
2024-09-16−4,357,146→ 0 total(indirect: See Note 3)→ Common Stock (501,796 underlying) - Conversion
Series C Convertible Preferred Stock
2024-09-16−5,809,528→ 0 total(indirect: See Note 4)→ Common Stock (669,061 underlying) - Purchase
Common Stock
2024-09-16$17.00/sh+1,352,942$23,000,014→ 1,854,738 total(indirect: See Note 3) - Conversion
Common Stock
2024-09-16+501,796→ 501,796 total(indirect: See Note 3) - Purchase
Common Stock
2024-09-16$17.00/sh+441,176$7,499,992→ 1,110,237 total(indirect: See Note 4) - Conversion
Series C Convertible Preferred Stock
2024-09-16−13,071,439→ 0 total(indirect: See Note 2)→ Common Stock (1,505,388 underlying) - Purchase
Common Stock
2024-09-16$17.00/sh+441,176$7,499,992→ 1,946,564 total(indirect: See Note 2) - Conversion
Common Stock
2024-09-16+669,061→ 669,061 total(indirect: See Note 4) - Conversion
Common Stock
2024-09-16+1,505,388→ 1,505,388 total(indirect: See Note 2)
SR ONE CAPITAL MANAGEMENT, LLC
10% Owner
Transactions
- Conversion
Series C Convertible Preferred Stock
2024-09-16−13,071,439→ 0 total(indirect: See Note 2)→ Common Stock (1,505,388 underlying) - Purchase
Common Stock
2024-09-16$17.00/sh+441,176$7,499,992→ 1,110,237 total(indirect: See Note 4) - Purchase
Common Stock
2024-09-16$17.00/sh+441,176$7,499,992→ 1,946,564 total(indirect: See Note 2) - Conversion
Common Stock
2024-09-16+501,796→ 501,796 total(indirect: See Note 3) - Conversion
Common Stock
2024-09-16+669,061→ 669,061 total(indirect: See Note 4) - Conversion
Series C Convertible Preferred Stock
2024-09-16−4,357,146→ 0 total(indirect: See Note 3)→ Common Stock (501,796 underlying) - Purchase
Common Stock
2024-09-16$17.00/sh+1,352,942$23,000,014→ 1,854,738 total(indirect: See Note 3) - Conversion
Common Stock
2024-09-16+1,505,388→ 1,505,388 total(indirect: See Note 2) - Conversion
Series C Convertible Preferred Stock
2024-09-16−5,809,528→ 0 total(indirect: See Note 4)→ Common Stock (669,061 underlying)
Footnotes (4)
- [F1]On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
- [F2]The reported securities are held directly by SR One Capital Fund II Aggregator, LP. SR One Capital Partners II, LP is the general partner of SR One Capital Fund II Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners II, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Partners II, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- [F3]The reported securities are held directly by AMZL, LP. SR One Capital SMA Partners, LP is the general partner of AMZL, LP, and SR One Capital Management, LLC is the general partner of SR One Capital SMA Partners, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital SMA Partners, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- [F4]The reported securities are held directly by SR One Capital Opportunities Fund I, LP. SR One Capital Opportunities Partners I, LP is the general partner of SR One Capital Opportunities Fund I, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Opportunities Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Opportunities Partners I, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
Documents
Issuer
Zenas BioPharma, Inc.
CIK 0001953926
Entity typeother
Related Parties
1- filerCIK 0001595117
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 8:51 PM ET
- Size
- 23.0 KB